Feasibility study of 21-day-on/7-day-off temozolomide in children with brain tumors

By Ridola Vita   Barone Giuseppe   Lazzareschi Ilaria   Ruggiero Antonio   Rizzo Daniela   Riccardi Riccardo  

Journal of Neuro-Oncology, Vol. 103, Iss. 1, 2011-05 ,pp. : 147-153

Springer Publishing Company

Access to resources Recommend Favorite

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

By Christodoulou Christos   Bafaloukos Dimitrios   Linardou Helen   Aravantinos Gerassimos   Bamias Aristotelis   Carina Maria   Klouvas George   Skarlos Dimosthenis  

Journal of Neuro-Oncology, Vol. 71, Iss. 1, 2005-01 ,pp. : 61-65

Springer Publishing Company

Access to resources Recommend Favorite

BRAIN TUMORS

By  

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 1-1

Informa Healthcare

Access to resources Recommend Favorite

Response of low-grade oligodendroglial tumors to temozolomide

By Byrne Thomas  

Journal of Neuro-Oncology, Vol. 70, Iss. 3, 2004-12 ,pp. : 279-280

Springer Publishing Company

Access to resources Recommend Favorite

Temozolomide With or Without Radiotherapy in Melanoma With Unresectable Brain Metastases

By Hofmann Maja   Kiecker Felix   Wurm Reinhard   Schlenger Lorenz   Budach Volker   Sterry Wolfram   Trefzer Uwe  

Journal of Neuro-Oncology, Vol. 76, Iss. 1, 2006-01 ,pp. : 59-64

Springer Publishing Company

Access to resources Recommend Favorite